Skip to Content

LDK 150MG NVR (Zykadia 150 mg)

Generic Name: ceritinib

Pill with imprint LDK 150MG NVR is Blue & White, Capsule-shape and has been identified as Zykadia 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.

Zykadia is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zykadia 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LDK 150MG NVR

Zykadia

Generic Name
ceritinib
Imprint
LDK 150MG NVR
Strength
150 mg
Color
Blue & White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Novartis Pharmaceuticals Corporation
National Drug Code (NDC)
00078-0640

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.